Nice | Apixaban for the treatment of DVT and PE

27th July 2015 by Louise Hudman

Nice | Apixaban for the treatment of DVT and PE

This is a new guideline from Nice on apixaban. It has now been approved for the treatment of and secondary prevention of DVT and VTE.

Now dabigatran, rivaroxaban and apixaban can all be used in AF, for the prevention of VTE after hip surgery and for treatment and secondary prevention of DVT and PE.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"I have been a member of the NASGP for about 18 months and find the support and advice invaluable.

It was especially helpful when I started locum work. I think I must have spent hours on the website devouring every single article as I was keen to learn all I could before I went solo. "

Dr Sally Watkins

Dr Sally Watkins

See the full list of features within our NASGP membership plans

Membership